VivoSeq
Other

Aesthetic

0

Pipeline Programs

6

Active Trials

1

Companies Involved

Aesthetic is an early-stage landscape with 0 programs across 1 company. The most active players are i+Med S.Coop..

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

89/100

Attrition Rate

4/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

27

clinical trials

Completed17 · 63%
Active, not recruiting4 · 15%
Unknown status2 · 7%
Recruiting2 · 7%
Suspended1 · 4%
Withdrawn1 · 4%

Trial Activity

27 trials

A Novel Substrate and Injection Technique for Chin Augmentation
Active, not recruiting·EErevna Innovations Inc.·Preclinical·NCT07193199·21 enrolled
The Use of Topical Anaesthetic in the Banding of Internal Haemorrhoids
Completed··Phase 2·NCT04031131·38 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)